Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

NCT00180011 is registered in ClinicalTrials.gov with DiMango, Emily, M.D. as lead sponsor.

NCT NCT00180011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00180011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
Lead sponsor
DiMango, Emily, M.D.
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2005
Completion date
February 29, 2012
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma